Thallium, Urine

Clinical Use

Order Test

Use

Monitor industrial exposure to thallium

Special Instructions

Not provided.

Limitations

The test performance characteristics have been determined by LabCorp, but it has not been cleared or approved by the Food and Drug Administration. As such, there may be limitations in its use due to the lack of FDA approval, which may affect its validity in certain clinical or regulatory contexts.

Test Details

Methodology

Mass Spectrometry

Biomarkers

Creatinine, Urine

Analyte

Creatinine, Urine

Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)

Thallium, Urine

Analyte

Thallium, Urine

Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)

Thallium/Creatinine Ratio

Analyte

Thallium/Creatinine Ratio

Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)

LOINC Codes

Order Codes

21558-2 - Thallium 24h Ur-mCnc

Result Codes

21558-2 - Thallium 24h Ur-mCnc
2161-8 - Creat Ur-mCnc
13469-2 - Thallium/Creat Ur

Result Turnaround Time

4-6 days

Specimen

Urine

Volume

5 mL

Minimum Volume

1.5 mL

Container

Plastic urine container, no preservative

Collection Instructions

Instruct the patient to void at 8 AM and discard the specimen. Then collect all urine including the final specimen voided at the end of the 24-hour collection period (i.e., 8 AM the next morning). Avoid contact with metal during collection. Screw the lid on securely.